CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Oliver D. Howes

OPENALEX: A5001601365↗ORCID: 0000-0002-2928-1972↗

Affiliations

Organizations

Hammersmith Hospitalauthorship · GB Imperial College Londonauthorship · GB King's College Londonauthorship · GB Kings Health Partnersauthorship · GB Medical Research Councilauthorship · GB MRC Clinical Trials Unit at UCLauthorship · GB MRC London Institute of Medical Sciencesauthorship · GB South London and Maudsley NHS Foundation Trustauthorship · GB

Public evidence

5 connected articles

Individual and combined effects of cannabidiol and Δ<sup>9</sup>-tetrahydrocannabinol on striato-cortical connectivity in the human brain.2022 · Europe PMC Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis.2021 · PubMed Central Open Access Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.2020 · Europe PMC The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.2019 · Europe PMC Salience attribution and its relationship to cannabis-induced psychotic symptoms.2016 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Oliver D. Howes - Medical Cannabis Research Engine